跳至主要内容
临床试验/CTRI/2023/05/052463
CTRI/2023/05/052463尚未招募3 期

A RANDOMIZED CONTROLLED CLINICAL STUDY ON SHARPUNKHADI GRANULES IN CHILDHOOD SICKLE CELL DISEASE

Parul Institute of Ayurved0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Pre diagnosed cases will be taken only with positive sickling report
  • 2 Age between 3 years to 16 years irrespective of gender caste religion
  • 3 Patients with sign and symptoms of sickle cell disease
  • 4 Hb >6.5 gm% and <11.5 gm%
  • 5 Hb electrophoresis reporting % of Hb S >10 gm%
  • 6 Serum Bilirubin less than 3.0 mg/dL

排除标准

  • 1 Age less than 3 years and greater than 16 years
  • 2 Patients with known case of hepatic and renal dysfunction and chronic cardiac dysfunction
  • 3 SCA associated with other known diseases like Diabetes Mellitus Hypertension Thalassemia
  • 4 Hb < 6.5 gm % and >11.5 gm %
  • 5 Serum bilirubin level more than 3.0mg/dL
  • 6 Known case of other haemoglobinopathies and haematological diseases other than sickle cell anaemia G6PD thalassemia sickle cell beta thalassemia

研究者

发起方
Parul Institute of Ayurved

相似试验